Matthew Stanton - 15 Jul 2023 Form 4 Insider Report for Generation Bio Co. (GBIO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jul 2023, 16:35:14 UTC
Prior SEC filing
18 Apr 2023
Next SEC filing
17 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Benjamin Waters, Attorney-in-Fact

Key filing fact

Matthew Stanton filed Form 4 for Generation Bio Co. (GBIO) on 18 Jul 2023.

Key facts

  • This page summarizes Matthew Stanton's Form 4 filing for Generation Bio Co. (GBIO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jul 2023, 16:35.

Change

  • Previous filing in this sequence was filed on 18 Apr 2023.
  • Current net transaction value: -$11,090.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GBIO transaction

Common Stock

Options Exercise

Transaction value
Shares
+7,437
Change %
+3.3%
Price
Shares after
231,468
Date
15 Jul 2023
Ownership
Direct
Footnotes
F1
GBIO transaction

Common Stock

Tax liability

Transaction value
$11,090
Shares
-2,183
Change %
-0.94%
Price
$5.08
Shares after
229,285
Date
15 Jul 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GBIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-7,437
Change %
-33%
Price
$0.000000
Shares after
14,874
Date
15 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,437
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents the right to receive one share of the company's common stock.

Footnote F2

On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .